Glucosylation drives the innate inflammatory response to clostridium difficile toxin A

Infection and Immunity

Volumn 84, Issue 8, 2016, Pages 2317-2323

  Cowardin, Carrie A ^a   Jackman, Brianna M ^b   Noor, Zannatun ^a   Burgess, Stacey L ^a   Feig, Andrew L ^b   Petri, William A ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CXCL1 CHEMOKINE; GLUCOSYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; AUTACOID; BACTERIAL TOXIN; BIOLOGICAL MARKER; CYTOKINE; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; GLYCOSYLATION; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; ANIMAL; CLOSTRIDIUM INFECTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PEPTOCLOSTRIDIUM DIFFICILE;

ANIMALS; BACTERIAL TOXINS; BIOMARKERS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CYTOKINES; ENTEROTOXINS; GLYCOSYLATION; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MALE; MICE; NF-KAPPA B;

EID: 84979775141     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00327-16     Document Type: Article

References (29)

1. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. 2015. Burden of Clostridium difficile infection in the United States. N Engl J Med 372:825-834. http://dx.doi.org/10.1056/NEJMoa1408913.
2. Ananthakrishnan AN. 2011. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 8:17-26. http://dx.doi.org/10.1038/nrgastro.2010.190.
3. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713. http://dx.doi.org/10.1038/nature09397.
4. Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP. 2014. The importance of toxin A, toxin B and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis. 209:83-86. http://dx.doi.org/10.1093/infdis/jit426.
5. Carter GP, Chakravorty A, Nguyen TAP, Mileto S, Schreiber F, Li L, Howarth P, Clare S, Cunningham B, Sambol SP, Cheknis A, Figueroa I, Johnson S, Gerding D, Rood JI, Dougan G, Lawley TD, Lyras D. 2015. Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections. mBio 6:e00551-15. http://dx.doi.org/10.1128/mBio.00551-15.
6. Carter GP, Rood JI, Lyras D. 2010. The role of toxin A and toxin B in Clostridium difficile-associated disease. Gut Microbes 1:58-64. http://dx.doi.org/10.4161/gmic.1.1.10768.
7. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt W-D, Wehland J, Aktories K. 2009. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 5:e1000626. http://dx.doi.org/10.1371/journal.ppat.1000626.
8. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. 1985. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun47:349-352.
9. Matarrese P, Falzano L, Fabbri A, Gambardella L, Frank C, Geny B, Popoff MR, Malorni W, Fiorentini C. 2007. Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels. J Biol Chem 282:9029-9041.
10. Pruitt RN, Lacy DB. 2012. Toward a structural understanding of Clostridium difficile toxins A and B. Front Cell Infect Microbiol 2:28.
11. Chumbler NM, Farrow MA, Lapierre LA, Franklin JL, Haslam D, Goldenring JR, Lacy DB. 2012. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog 8:e1003072. http://dx.doi.org/10.1371/journal.ppat.1003072.
12. Wohlan K, Goy S, Olling A, Srivaratharajan S, Tatge H, Genth H, Gerhard R. 2014. Pyknotic cell death induced by Clostridium difficile TcdB: chromatin condensation and nuclear blister are induced independently of the glucosyltransferase activity. Cell Microbiol 16:1678-1692. http://dx.doi.org/10.1111/cmi.12317.
13. Auria KM, Bloom DMJ, Reyes Y, Gray MC, van Opstal EJ, Papin JA, Hewlett EL. 2015. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types. BMC Microbiol 15:7. http://dx.doi.org/10.1186/s12866-015-0361-4.
14. Gerhard R, Nottrott S, Schoentaube J, Tatge H, Olling A, Just I. 2008. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J Med Microbiol 57:765-770. http://dx.doi.org/10.1099/jmm.0.47769-0.
15. Nottrott S, Schoentaube J, Genth H, Just I, Gerhard R. 2007. Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases. Apoptosis 12:1443-1453. http://dx.doi.org/10.1007/s10495-007-0074-8.
16. Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, Potentier MS, Schenck LP, Vilaysane A, Seamone ME, Feng H, Armstrong GD, Tschopp J, Macdonald JA, Muruve DA, Beck PL. 2010. Clostridium difficile toxininduced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology 139:542-552, 552.e1-552e.3. http://dx.doi.org/10.1053/j.gastro.2010.04.005.
17. Xu H, Yang J, Gao W, Li L, Li P, Zhang L, Gong Y-N, Peng X, Xi JJ, Chen S, Wang F, Shao F. 2014. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513:237-241. http://dx.doi.org/10.1038/nature13449.
18. Sun X, He X, Tzipori S, Gerhard R, Feng H. 2009. Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-α by macrophages. Microb Pathog 46:298-305. http://dx.doi.org/10.1016/j.micpath.2009.03.002.
19. von Moltke J, Ayres JS, Kofoed EM, Chavarría-Smith J, Vance RE. 2013. Recognition of bacteria by inflammasomes. Annu Rev Immunol 31:73-106. http://dx.doi.org/10.1146/annurev-immunol-032712-095944.
20. Teichert M, Tatge H, Schoentaube J, Just I, Gerhard R. 2006. Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effects. Infect Immun 74:6006-6010. http://dx.doi.org/10.1128/IAI.00545-06.
21. Yang G, Zhou B, Wang J, He X, Sun X, Nie W, Tzipori S, Feng H. 2008. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium. BMC Microbiol 8:192. http://dx.doi.org/10.1186/1471-2180-8-192.
22. Bai L, Feuerer M, Beckhove P, Umansky V, Schirrmacher V. 2002. Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells. Int J Oncol 20:247-253.
23. D'Auria KM, Kolling GL, Donato GM, Warren CA, Gray MC, Hewlett EL, Papin JA. 2013. In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B. Infect Immun 81:3814-3824. http://dx.doi.org/10.1128/IAI.00869-13.
24. Steele J, Chen K, Sun X, Zhang Y, Wang H, Tzipori S, Feng H. 2012. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J Infect Dis 205:384-391. http://dx.doi.org/10.1093/infdis/jir748.
25. Hunter CA, Jones SA. 2015. IL-6 as a keystone cytokine in health and disease. Nat Immunol 16:448-457. http://dx.doi.org/10.1038/ni.3153.
26. McDermott AJ, Frank CR, Falkowski NR, McDonald RA, Young VB, Huffnagle GB. 2014. Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice. Gut Microbes 5:1-9. http://dx.doi.org/10.4161/gmic.28028.
27. Song F, Ito K, Denning TL, Kuninger D, Papaconstantinou J, Gourley W, Klimpel G, Balish E, Hokanson J, Ernst PB. 1999. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines. J Immunol 162:2275-2280.
28. Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A. 2004. Phospholipases C and A2 control lysosome-mediated IL-1β secretion: implications for inflammatory processes. Proc Natl Acad Sci U S A 101:9745-9750. http://dx.doi.org/10.1073/pnas.0308558101.
29. Pelegrin P, Barroso-Gutierrez C, Surprenant A. 2008. P2X7 receptor differentially couples to distinct release pathways for IL-1β in mouse macrophage. J Immunol 180:7147-7157. http://dx.doi.org/10.4049/jimmunol.180.11.7147.